Drug Discovery · South San Francisco, CA · Founded 2008 · Privately Held (backing)
Developer of regenerative cell therapies designed for the treatment of chronic neurological disorders. Neurona Therapeutics is based in South San Francisco, CA and was founded in 2008. It is valued at about $1.1 billion as of Oct 2026, set by institutional fund marks. It has raised $348 million across 6 recorded rounds; the latest was a $102 million Series F in Mar 2025.
PMV mark · valuation
$1.1B
Oct 2026
Priced at
a merger or acquisition
Apr 2026
Total raised
$347.6M
Last round
Later Stage VC (Series F)
Mar 2025
Cap table — not yet on record
Neurona Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Where does Neurona Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Neurona Therapeutics's 6 recorded funding rounds.
